Cocaine decreases the expression of PSA-NCAM protein and attenuates long-term potentiation via glucocorticoid receptors in the rat dentate gyrus

Eur J Neurosci. 2008 Jun;27(11):2928-37. doi: 10.1111/j.1460-9568.2008.06255.x.

Abstract

The present study investigated a potential role for glucocorticoid (GR) and mineralocorticoid (MR) receptors in the detrimental effects of single cocaine (COC) administration on both the number of polysialylated neural cell adhesion molecule (PSA-NCAM)-positive neurons and the induction of long-term potentiation (LTP) in the rat dentate gyrus (DG). The effects of COC (15 mg/kg i.p.) on the number of PSA-NCAM-positive neurons and the induction of LTP observed 2 days after COC administration were abolished either by depleting circulating corticosterone after administration of metyrapone (100 mg/kg s.c. given 3 h before COC) or by pharmacologically blocking GRs using mifepristone (RU 38486, 10 mg/kg s.c. given 1 h before COC). Administration of the MR blocker spironolactone (50 mg/kg s.c. given 1 h before COC) did not alter the effects of COC on the number of PSA-NCAM-positive neurons or LTP induction. Results have also shown that COC does not change the rate of cell proliferation, as measured by the presence of Ki-67 and the incorporation of bromodeoxyuridine (100 mg/kg i.p. given 2 h after COC) into the newly born cells in the DG 2 days after COC administration. Finally, we observed that GRs colocalized with some, but not all, PSA-NCAM-positive neurons, whereas MRs showed no colocalization with neurons positive for PSA-NCAM in the DG. These data indicate that a single dose of COC may arrest hippocampal susceptibility to plastic changes and lead to functional impairments through the alteration of hippocampal structure and the formation of memory traces.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bromodeoxyuridine
  • Cell Count
  • Cell Proliferation / drug effects
  • Cocaine / pharmacology*
  • Cocaine-Related Disorders / metabolism*
  • Cocaine-Related Disorders / physiopathology
  • Corticosterone / antagonists & inhibitors
  • Corticosterone / blood
  • Dentate Gyrus / drug effects*
  • Dentate Gyrus / metabolism
  • Dopamine Uptake Inhibitors / pharmacology
  • Down-Regulation / drug effects
  • Down-Regulation / physiology
  • Ki-67 Antigen / metabolism
  • Long-Term Potentiation / drug effects*
  • Long-Term Potentiation / physiology
  • Male
  • Memory / drug effects
  • Memory / physiology
  • Memory Disorders / chemically induced
  • Memory Disorders / metabolism
  • Memory Disorders / physiopathology
  • Metyrapone / analogs & derivatives
  • Metyrapone / pharmacology
  • Mifepristone / pharmacology
  • Mineralocorticoid Receptor Antagonists
  • Neural Cell Adhesion Molecule L1 / metabolism*
  • Neurons / drug effects
  • Neurons / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, Glucocorticoid / agonists*
  • Receptors, Glucocorticoid / antagonists & inhibitors
  • Receptors, Glucocorticoid / metabolism
  • Receptors, Mineralocorticoid / metabolism
  • Sialic Acids / metabolism*
  • Spironolactone / pharmacology

Substances

  • Dopamine Uptake Inhibitors
  • Ki-67 Antigen
  • Mineralocorticoid Receptor Antagonists
  • Neural Cell Adhesion Molecule L1
  • Receptors, Glucocorticoid
  • Receptors, Mineralocorticoid
  • Sialic Acids
  • polysialyl neural cell adhesion molecule
  • metyrapol
  • Spironolactone
  • Mifepristone
  • Bromodeoxyuridine
  • Cocaine
  • Corticosterone
  • Metyrapone